Compelo Medical Devices - Latest industry news and analysis is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More

BD adds new cytometer to industrial microbiology portfolio

BD Biosciences and BD Diagnostics, two business segments of BD (Becton, Dickinson and Company) (BDX), have added a new BD FACSMicroCount flow cytometry system to the industrial microbiology portfolio.

BD obtained worldwide rights from Advanced Analytical Technologies to market the instrument, with prior name Micro PRO Microbial Detection System.

The BD FACSMicroCount system screens a variety of microorganisms including bacteria, yeast, mold, spirochetes, Mycoplasma, and parasite cysts.

The system reduces the time to result and automates traditional methods, helping to reduce production cycles and achieve cost savings, especially in labor, inventory and warehouse costs.

The BD FACSMicroCount System is designed for rapid microbial enumeration and detection.

BD Diagnostics president Tom Polen said adding this instrument to their portfolio supports BD’s growth-through-innovation strategy and reinforces their position as a leader in industrial microbiology by offering customers the widest choice of microbial detection platforms.

"While complementing our existing microbiology media and PCR products, this new system satisfies an important customer need that helps ensure product safety and meet ever-increasing compliance standards," Polen said.